TCBPY — TC Biopharm (Holdings) Balance Sheet
0.000.00%
Last trade - 00:00- $0.08m
- -$1.55m
Annual balance sheet for TC Biopharm (Holdings), fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 20-F | 10-K | 10-K | 20-F |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.748 | 1.57 | 4.81 | 2.46 | 1.22 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.24 | 1.48 | 1.78 | 1.1 | 0.66 |
| Prepaid Expenses | |||||
| Total Current Assets | 2.22 | 3.86 | 7.45 | 5.7 | 5.77 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.63 | 3.68 | 3.29 | 2.62 | 2.09 |
| Net Intangible Assets | |||||
| Total Assets | 7.27 | 8.02 | 11.3 | 8.93 | 8.33 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.19 | 20.6 | 9.16 | 4.75 | 4.15 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.6 | 24.6 | 11 | 6.25 | 5.32 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -3.35 | -16.6 | 0.331 | 2.69 | 3.01 |
| Total Liabilities & Shareholders' Equity | 7.27 | 8.02 | 11.3 | 8.93 | 8.33 |
| Total Common Shares Outstanding |